Development of luciferase reporter-based cell assays

Assay and Drug Development Technologies

Volumn 4, Issue 3, 2006, Pages 307-315

  Lai, Chunfai ^a   Jiang, Xin ^a   Li, Xianqiang ^a  

^a Panomics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA,17BETA DIHYDROXY 6 METHYL 17ALPHA (1 PROPYNYL)ANDROSTA 1,4,6 TRIEN 3 ONE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEXAMETHASONE; DNA; FLUTICASONE PROPIONATE; GLUCOCORTICOID RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MIFEPRISTONE; SERUM RESPONSE FACTOR; STAT1 PROTEIN; STAT3 PROTEIN; STEROID RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TRIAMCINOLONE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CELL ASSAY; CELL LINE; CELL SPECIFICITY; CELL STRAIN 3T3; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; EXPERIMENTAL MODEL; GENE ACTIVITY; HELA CELL; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; LIGAND BINDING; PROMOTER REGION; RECEPTOR BINDING; REPORTER GENE; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL ASSAY; CYTOKINES; GENES, REPORTER; HUMANS; LUCIFERASES; LUMINESCENT MEASUREMENTS;

EID: 33746160313     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2006.4.307     Document Type: Article

References (30)

1. Hunter T: Signaling - 2000 and beyond. Cell 2000;100: 113-127.
2. Pawson T, Saxton TM: Signaling networks - do all roads lead to the same genes? Cell 1999;97:675-678.
3. Adhikary S, Eilers M: Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 2005;6:635-645.
4. Krause DS, Van Etten RA: Tyrosine kinases as targets for cancer therapy. N Engl J Med 2005;353:172-187.
5. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, et al.: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244: 707-712.
6. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, et al.: Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005;353:1673-1684.
7. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, et al.: Herceptin Adjuvant (HERA) Trial Study Team: Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005;353:1659-1672.
8. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al.: The sequence of the human genome. Science 2001;291:1304-1351.
9. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al.: International Human Genome Sequencing Consortium: Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
10. Austin CP: The impact of the completed human genome sequence on the development of novel therapeutics for human disease. Annu Rev Med 2004;55:1-13.
11. Berger J, Hauber J, Hauber R, Geiger R, Cullen BR: Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 1988;66:1-10.
12. Tsien RY: The green fluorescent protein. Annu Rev Biochem 1998;67:509-544.
13. Thompson JF, Hayes LS, Lloyd DB: Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene 1991;103:171-177.
14. Hayden MS, Ghosh S: Signaling to NF-kappaB. Genes Dev 2004;18:2195-2224.
15. Karin M, Lin A: NF-kappaB at the crossroads of life and death. Nat Immunol 2002;3:221-227.
16. Barnes PJ, Karin M: Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071.
17. Lin A, Karin M: NF-kappaB in cancer: a marked target. Semin Cancer Biol 2003;13:107-114.
18. Los M, Schenk H, Hexel K, Baeuerle PA, Droge W, Schulze-Osthoff K: IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J 1995;14:3731-3740.
19. Kuprash DV, Udalova IA, Turetskaya RL, Rice NR, Nedospasov SA: Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages. Oncogene 1995;11:97-106.
20. Beinke S, Robinson MJ, Hugunin M, Ley SC: Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105. Mol Cell Biol 2004;24:9658-9667.
21. Keicho N, Higashimoto Y, Bondy GP, Elliott WM, Hogg JC, Hayashi S: Endotoxin-specific NF-kappaB activation in pulmonary epithelial cells harboring adenovirus E1A. Am J Physiol 1999;277:L523-L532.
22. Semenza GL: HIF-1 and human disease: one highly involved factor. Genes Dev 2000;14:1983-1991.
23. Phillips RJ, Mestas J, Gharaee-Kermani M, Burdick MD, Sica A, Belperio JA, et al.: Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. J Biol Chem 2005;280: 22473-22481.
24. Chau NM, Rogers P, Aherne W, Carroll V, Collins I, McDonald E, et al.: Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors. Cancer Res 2005;65:4918-4928.
25. Rapisarda A, Uranchimeg B, Scudiero DA, Selby M, Sausville EA, Shoemaker RH, et al.: Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res 2002;62: 4316-4324.
26. Kumar R, Thompson EB: Gene regulation by the glucocorticoid receptor: structure:function relationship. J Steroid Biochem Mol Biol 2005;94:383-394.
27. Honer C, Nam K, Fink C, Marshall P, Ksander G, Chatelain RE, et al.: Glucocorticoid receptor antagonism by cyproterone acetate and RU486. Mol Pharmacol 2003; 63:1012-1020.
28. Adcock IM, Ito K, Barnes PJ: Glucocorticoids: effects on gene transcription. Proc Am Thorac Soc 2004;1:247-254.
29. Civelli O: GPCR deorphanizations: the novel, the known and the unexpected transmitters. Trends Pharmacol Sci 2005;26:15-19.
30. Silva J, Chang K, Hannon GJ, Rivas FV: RNA-interference-based functional genomics in mammalian cells: reverse genetics coming of age. Oncogene 2004;23:8401-8409.